Moreover, CUR interferes with the PI3K/Akt/mTOR pathway through its regulatory role on key molecule players of AKT, PTEN, HER2, and mTOR, which may facilitate the inhibition of cellular growth, invasion, and metastasis in breast cancer [34,35,36]. The gene discussed is AKT1; the disease is breast cancer.